187 related articles for article (PubMed ID: 17147378)
1. Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer.
Tichenor MS; Trzupek JD; Kastrinsky DB; Shiga F; Hwang I; Boger DL
J Am Chem Soc; 2006 Dec; 128(49):15683-96. PubMed ID: 17147378
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis and evaluation of iso-duocarmycin SA and iso-yatakemycin.
MacMillan KS; Nguyen T; Hwang I; Boger DL
J Am Chem Soc; 2009 Jan; 131(3):1187-94. PubMed ID: 19154178
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin.
Tichenor MS; Kastrinsky DB; Boger DL
J Am Chem Soc; 2004 Jul; 126(27):8396-8. PubMed ID: 15237994
[TBL] [Abstract][Full Text] [Related]
4. Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity.
Tichenor MS; MacMillan KS; Trzupek JD; Rayl TJ; Hwang I; Boger DL
J Am Chem Soc; 2007 Sep; 129(35):10858-69. PubMed ID: 17691783
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
[TBL] [Abstract][Full Text] [Related]
6. Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis.
Ellis DA; Wolkenberg SE; Boger DL
J Am Chem Soc; 2001 Sep; 123(38):9299-306. PubMed ID: 11562212
[TBL] [Abstract][Full Text] [Related]
7. Yatakemycin: total synthesis, DNA alkylation, and biological properties.
Tichenor MS; Boger DL
Nat Prod Rep; 2008 Apr; 25(2):220-6. PubMed ID: 18389136
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
Boger DL; Johnson DS; Yun W; Tarby CM
Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
[TBL] [Abstract][Full Text] [Related]
9. DNA alkylation properties of yatakemycin.
Parrish JP; Kastrinsky DB; Wolkenberg SE; Igarashi Y; Boger DL
J Am Chem Soc; 2003 Sep; 125(36):10971-6. PubMed ID: 12952479
[TBL] [Abstract][Full Text] [Related]
10. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
Boger DL; Stauffer F; Hedrick MP
Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
[TBL] [Abstract][Full Text] [Related]
11. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
Boger DL; Johnson DS
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
[TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins.
Tichenor MS; MacMillan KS; Stover JS; Wolkenberg SE; Pavani MG; Zanella L; Zaid AN; Spalluto G; Rayl TJ; Hwang I; Baraldi PG; Boger DL
J Am Chem Soc; 2007 Nov; 129(45):14092-9. PubMed ID: 17948994
[TBL] [Abstract][Full Text] [Related]
13. DNA sequence selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145.
Kiakos K; Sato A; Asao T; McHugh PJ; Lee M; Hartley JA
Mol Cancer Ther; 2007 Oct; 6(10):2708-18. PubMed ID: 17938264
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]imidazolo[4,5-e]indol-4-one-6-carboxylate (CImI) alkylation subunit.
Chanda PB; Boyle KE; Brody DM; Shukla V; Boger DL
Bioorg Med Chem; 2016 Oct; 24(20):4779-4786. PubMed ID: 27221071
[TBL] [Abstract][Full Text] [Related]
15. Selective metal cation activation of a DNA alkylating agent: synthesis and evaluation of methyl 1,2,9, 9a-Tetrahydrocyclopropa[c]pyrido[3,2-e]indol-4-one-7-carboxylate (CPyI).
Boger DL; Boyce CW
J Org Chem; 2000 Jun; 65(13):4088-100. PubMed ID: 10866626
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]oxazolo[2,3-e]indol-4-one-6-carboxylate (COI) alkylation subunit.
Boyle KE; MacMillan KS; Ellis DA; Lajiness JP; Robertson WM; Boger DL
Bioorg Med Chem Lett; 2010 Mar; 20(6):1854-7. PubMed ID: 20171886
[TBL] [Abstract][Full Text] [Related]
17. The structural basis for in situ activation of DNA alkylation by duocarmycin SA.
Smith JA; Bifulco G; Case DA; Boger DL; Gomez-Paloma L; Chazin WJ
J Mol Biol; 2000 Jul; 300(5):1195-204. PubMed ID: 10903864
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.
Robertson WM; Kastrinsky DB; Hwang I; Boger DL
Bioorg Med Chem Lett; 2010 May; 20(9):2722-5. PubMed ID: 20381346
[TBL] [Abstract][Full Text] [Related]
19. Alkylation of duplex DNA in nucleosome core particles by duocarmycin SA and yatakemycin.
Trzupek JD; Gottesfeld JM; Boger DL
Nat Chem Biol; 2006 Feb; 2(2):79-82. PubMed ID: 16415862
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
Boger DL; Hughes TV; Hedrick MP
J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
